Robert F. Kennedy Jr., US secretary of Health and Human Services (HHS), during an announcement at the Health and Human Services headquarters in Washington, DC, US, on Monday, Oct. 5, 2026. Image source, Getty Images
BySareen Habeshian
  • Published27 minutes ago

US Health Secretary Robert F Kennedy Jr. has released plans to loosen restrictions on controversial peptides.

The plans, which were announced in the US Federal Register on Wednesday, say Kennedy would allow compounding pharmacies to prepare six popular peptides, which not been approved by the Food and Drug Administration (FDA).

In an unusual move, the draft came from the office of the health secretary rather than the FDA. After the plan has been officially published later this week, there will be a two-week public comment period.